EBOLA VIRUS: GENETIC DIVERSITY, SYMPTOMS, DIAGNOSIS AND TREATMENTS

Main Article Content

GANIMA NAZ
NEERAJ PANDEY

Abstract

Ebola virus is one of the most deadly pathogen known to infect humans Ebola virus disease has been diagnosed in the US, originating from patients who travelled during incubation period.  The first recognized Ebola outbreak occurs in 1976 near the Ebola River in Zaire (now in Congo). Before the 2014 epidemic about 2300 cases with greater than 1500 death has been documented from this disease. Ebola virus belongs to the Filoviridae family and genus Ebola virus. The disease has evolved a global public health menace due to large immigrant population. It is also termed as Ebola hemorrhagic fever (EHF). The transmission of virus to people from wild animals and spreads with in the human population via human to human transmission. Pregnant women who are recovered from Ebola virus still carry the virus in breast milk or Symptoms of hemorrhagic in pregnancy related fluid and tissues.

Keywords:
Genetic diversity, symptoms, diagnosis, treatment

Article Details

How to Cite
NAZ, G., & PANDEY, N. (2020). EBOLA VIRUS: GENETIC DIVERSITY, SYMPTOMS, DIAGNOSIS AND TREATMENTS. Journal of Case Reports in Medical Science, 6(1), 1-4. Retrieved from https://ikprress.org/index.php/JOCRIMS/article/view/5236
Section
Mini Review Article

References

Feldman H, Sanchez A, Geisbert WT. Filoviridae: Marburg and ebola viruses. In: Knipe DM, Howley PM, editors. Fields in virology. Philadelphia: Lippincott Willams & Wilkins. 2013;923-956.

Mehedi M, Groseth A, Feldmann H, Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future Virol. 2011;6(9):1091–1106.

Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga B, Kabange F, Mbala Kingebeni P, et al. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med. 2014; 371(22):2083-2091.

WHO. Ebola Response Team. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481–1495.

Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371(22):2092-2100.

Sureau PH. Firsthand clinical observations of haemorrhagic manifestations in Ebola haemorrhagic fever in Zaire. Rev Infect Dis. 1989;11(Suppl 4):S790–S793.

Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768): 849–862.

Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014;371(15):1418–1425.

Burke J, Ghysebrechts SG, Pattyn SR, Piot P, Ruppol JF, Thonon D, et al. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56(2):271–293.

Muyembe-Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A, Paweska JT. Ebola virus outbreaks in Africa: Past and present. Onderstepoort J Vet Res. 2012; 79(2):451.

Chowell G, Nishiura H. Transmission dynamics and control of Ebola virus disease (EVD): a review. BMC Med. 2014;12(1):196.

Gulland A. Fifteen countries are at risk of Ebola outbreak, says WHO. BMJ. 2014;349: g6305.

Groseth A, Feldmann H, Strong JE. The ecology of Ebola virus. Trends Microbiol. 2007;15(9):408–416.

Ebola virus disease by Athena P. Kourtis. Kristie Appelgren and Anita McElroy. The pediatric infectious disease journal.